P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis

Breast Cancer Research

Volumn 12, Issue 5, 2010, Pages

  McHenry, Peter R ^a   Sears, James C ^a   Herrick, Matthew P ^c   Chang, Peggy ^a   Heckman Stoddard, Brandy M ^b   Rybarczyk, Megan ^a   Chodosh, Lewis A ^d   Gunther, Edward J ^e   Hilsenbeck, Susan G ^c   Rosen, Jeffrey M ^c   Vargo Gogola, Tracy ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; EPIDERMAL GROWTH FACTOR RECEPTOR 2; LAMININ; PROTEIN CDC42; PROTEIN P190B RHOGAP; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REGULATOR PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TETRACYCLINE; UNCLASSIFIED DRUG; ARHGAP5 PROTEIN, MOUSE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; RHO GTPASE ACTIVATING PROTEIN; RHO GTPASE-ACTIVATING PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST EPITHELIUM; BREAST METASTASIS; CANCER INVASION; CELL DIVISION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE OVEREXPRESSION; GROWTH RATE; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; ANIMAL; BIOSYNTHESIS; CELL ADHESION; CELL CULTURE; CELL MEMBRANE; CELL TRANSFORMATION; EPITHELIUM CELL; EXPERIMENTAL NEOPLASM; GENETICS; METABOLISM; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; UDDER;

ANIMALS; CDC42 GTP-BINDING PROTEIN; CELL ADHESION; CELL TRANSFORMATION, NEOPLASTIC; CELL-MATRIX JUNCTIONS; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; GTPASE-ACTIVATING PROTEINS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; RAC1 GTP-BINDING PROTEIN; REACTIVE OXYGEN SPECIES; RHOA GTP-BINDING PROTEIN;

EID: 78650949091     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2643     Document Type: Article

References (54)

1. Tang Y, Olufemi L, Wang MT, Nie D. Role of Rho GTPases in breast cancer. Front Biosci 2008, 13:759-776. 10.2741/2718, 17981586.
2. Sahai E, CJ. RHO-GTPases and Cancer. Nature Reviews Cancer 2002, 2:133-142. 10.1038/nrc725, 12635176.
3. Karlsson R, Pedersen ED, Wang Z, Brakebusch C. Rho GTPase function in tumorigenesis. Biochim Biophys Acta 2009, 1796:91-98.
4. Fritz G, Just I, Kaina B. Rho GTPases are over-expressed in human tumors. Int J Cancer 1999, 81:682-687. 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B, 10328216.
5. Fritz G, Brachetti C, Bahlmann F, Schmidt M, Kaina B. Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br J Cancer 2002, 87:635-644. 10.1038/sj.bjc.6600510, 2364248, 12237774.
6. McHenry PR, Vargo-Gogola T. Pleiotropic Functions of Rho GTPase Signaling: A Trojan Horse or Achilles' Heel for Breast Cancer Treatment?. Curr Drug Targets 11:1043-1058. 10.2174/138945010792006852, 20545614.
7. Zhang Y, Zhang B. D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness. Cancer Res 2006, 66:5592-5598. 10.1158/0008-5472.CAN-05-4004, 16740694.
8. Heckman-Stoddard BM, Vargo-Gogola T, McHenry PR, Jiang V, Herrick MP, Hilsenbeck SG, Settleman J, Rosen JM. Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression. Breast Cancer Res 2009, 11:R61. 10.1186/bcr2352, 2750123, 19703301.
9. Vincent S, Settleman J. Inhibition of RhoGAP activity is sufficient for the induction of Rho-mediated actin reorganization. Eur J Cell Biol 1999, 78:539-548.
10. Burbelo PD, Miyamoto S, Utani A, Brill S, Yamada KM, Hall A, Yamada Y. p190-B, a new member of the Rho GAP family, and Rho are induced to cluster after integrin cross-linking. J Biol Chem 1995, 270:30919-30926. 10.1074/jbc.270.52.30919, 8537347.
11. Bustos RI, Forget MA, Settleman JE, Hansen SH. Coordination of Rho and Rac GTPase function via p190B RhoGAP. Curr Biol 2008, 18:1606-1611. 10.1016/j.cub.2008.09.019, 18948007.
12. Heckman BM, Chakravarty G, Vargo-Gogola T, Gonzales-Rimbau M, Hadsell DL, Lee AV, Settleman J, Rosen JM. Crosstalk between the p190-B RhoGAP and IGF signaling pathways is required for embryonic mammary bud development. Dev Biol 2007, 309:137-149. 10.1016/j.ydbio.2007.07.002, 17662267.
13. Chakravarty G, Hadsell D, Buitrago W, Settleman J, Rosen JM. p190-B RhoGAP regulates mammary ductal morphogenesis. Mol Endocrinol 2003, 17:1054-1065. 10.1210/me.2002-0428, 12637587.
14. Vargo-Gogola T, Heckman BM, Gunther EJ, Chodosh LA, Rosen JM. P190-B Rho GTPase-activating protein overexpression disrupts ductal morphogenesis and induces hyperplastic lesions in the developing mammary gland. Mol Endocrinol 2006, 20:1391-1405. 10.1210/me.2005-0426, 16469769.
15. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, Werb Z, Bissell MJ. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005, 436:123-127. 10.1038/nature03688, 2784913, 16001073.
16. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003, 329:23-38. 10.1016/S0009-8981(03)00003-2, 12589963.
17. Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 1988, 54:105-115. 10.1016/0092-8674(88)90184-5, 2898299.
18. Gunther EJ, Belka GK, Wertheim GB, Wang J, Hartman JL, Boxer RB, Chodosh LA. A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J 2002, 16:283-292. 10.1096/fj.01-0551com, 11874978.
19. Schwertfeger KL, Xian W, Kaplan AM, Burnett SH, Cohen DA, Rosen JM. A critical role for the inflammatory response in a mouse model of preneoplastic progression. Cancer Res 2006, 66:5676-5685. 10.1158/0008-5472.CAN-05-3781, 16740705.
20. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003, 30:256-268. 10.1016/S1046-2023(03)00032-X, 12798140.
21. Kim A, Liu B, Ordonez-Ercan D, Alvarez KM, Jones LD, McKimmey C, Edgerton SM, Yang X, Thor AD. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells. Breast Cancer Res 2005, 7:R708-718. 10.1186/bcr1281, 1242139, 16168116.
22. Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ, Rehm S, Russo J, Tavassoli FA, Wakefield LM, Ward JM, Green JE. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 2000, 19:968-988. 10.1038/sj.onc.1203277, 10713680.
23. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006, 124:263-266. 10.1016/j.cell.2006.01.007, 16439202.
24. Jiang P, Enomoto A, Takahashi M. Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton. Cancer Lett 2009, 284:122-130. 10.1016/j.canlet.2009.02.034, 19303207.
25. Qiu RG, Chen J, Kirn D, McCormick F, Symons M. An essential role for Rac in Ras transformation. Nature 1995, 374:457-459. 10.1038/374457a0, 7700355.
26. Strumane K, Rygiel T, van der Valk M, Collard JG. Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice. J Cancer Res Clin Oncol 2009, 135:69-80. 10.1007/s00432-008-0437-8, 18592271.
27. Mori K, Shibanuma M, Nose K. Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res 2004, 64:7464-7472. 10.1158/0008-5472.CAN-04-1725, 15492271.
28. Ferraro D, Corso S, Fasano E, Panieri E, Santangelo R, Borrello S, Giordano S, Pani G, Galeotti T. Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS). Oncogene 2006, 25:3689-3698. 10.1038/sj.onc.1209409, 16462764.
29. Woo MS, Park JS, Choi IY, Kim WK, Kim HS. Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia. J Neurochem 2008, 106:770-780. 10.1111/j.1471-4159.2008.05430.x, 18419763.
30. Vega FM, Ridley AJ. Rho GTPases in cancer cell biology. FEBS Lett 2008, 582:2093-2101. 10.1016/j.febslet.2008.04.039, 18460342.
31. Hall A. The cytoskeleton and cancer. Cancer Metastasis Rev 2009, 28:5-14. 10.1007/s10555-008-9166-3, 19153674.
32. Schnelzer A, Prechtel D, Knaus U, Dehne K, Gerhard M, Graeff H, Harbeck N, Schmitt M, Lengyel E. Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 2000, 19:3013-3020. 10.1038/sj.onc.1203621, 10871853.
33. Akhtar N, Streuli CH. Rac1 links integrin-mediated adhesion to the control of lactational differentiation in mammary epithelia. J Cell Biol 2006, 173:781-793. 10.1083/jcb.200601059, 2063893, 16754961.
34. Pinkas J, Leder P. MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition. Cancer Res 2002, 62:4781-4790.
35. Wang F, Hansen RK, Radisky D, Yoneda T, Barcellos-Hoff MH, Petersen OW, Turley EA, Bissell MJ. Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J Natl Cancer Inst 2002, 94:1494-1503.
36. Xian W, Schwertfeger KL, Vargo-Gogola T, Rosen JM. Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3 D mammary epithelial cell model. J Cell Biol 2005, 171:663-673. 10.1083/jcb.200505098, 2171554, 16301332.
37. Mueller H, Flury N, Eppenberger-Castori S, Kueng W, David F, Eppenberger U. Potential prognostic value of mitogen-activated protein kinase activity for disease-free survival of primary breast cancer patients. Int J Cancer 2000, 89:384-388. 10.1002/1097-0215(20000720)89:4<384::AID-IJC11>3.0.CO;2-R, 10956414.
38. Ebisuya M, Kondoh K, Nishida E. The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity. J Cell Sci 2005, 118:2997-3002. 10.1242/jcs.02505, 16014377.
39. Bergqvist J, Elmberger G, Ohd J, Linderholm B, Bjohle J, Hellborg H, Nordgren H, Borg AL, Skoog L, Bergh J. Activated ERK1/2 and phosphorylated oestrogen receptor alpha are associated with improved breast cancer survival in women treated with tamoxifen. Eur J Cancer 2006, 42:1104-1112. 10.1016/j.ejca.2006.01.028, 16603346.
40. Svensson S, Jirstrom K, Ryden L, Roos G, Emdin S, Ostrowski MC, Landberg G. ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis. Oncogene 2005, 24:4370-4379. 10.1038/sj.onc.1208626, 15806151.
41. Milde-Langosch K, Bamberger AM, Rieck G, Grund D, Hemminger G, Muller V, Loning T. Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer. Br J Cancer 2005, 92:2206-2215. 10.1038/sj.bjc.6602655, 2361826, 15928662.
42. Westwick JK, Lambert QT, Clark GJ, Symons M, Van Aelst L, Pestell RG, Der CJ. Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways. Mol Cell Biol 1997, 17:1324-1335. 231857, 9032259.
43. Bouzahzah B, Albanese C, Ahmed F, Pixley F, Lisanti MP, Segall JD, Condeelis J, Joyce D, Minden A, Der CJ, Chan A, Symons M, Pestell RG. Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol Med 2001, 7:816-830. 1950008, 11844870.
44. Goryachev AB, Pokhilko AV. Computational model explains high activity and rapid cycling of Rho GTPases within protein complexes. PLoS Comput Biol 2006, 2:e172. 10.1371/journal.pcbi.0020172, 1676031,1676031, 17140284.
45. Lin R, Cerione RA, Manor D. Specific contributions of the small GTPases Rho, Rac, and Cdc42 to Dbl transformation. J Biol Chem 1999, 274:23633-23641. 10.1074/jbc.274.33.23633, 10438546.
46. Fidyk N, Wang JB, Cerione RA. Influencing cellular transformation by modulating the rates of GTP hydrolysis by Cdc42. Biochemistry 2006, 45:7750-7762. 10.1021/bi060365h, 16784226.
47. Lynch CC, Vargo-Gogola T, Martin MD, Fingleton B, Crawford HC, Matrisian LM. Matrix metalloproteinase 7 mediates mammary epithelial cell tumorigenesis through the ErbB4 receptor. Cancer Res 2007, 67:6760-6767. 10.1158/0008-5472.CAN-07-0026, 17638887.
48. Sundaresan M, Yu ZX, Ferrans VJ, Sulciner DJ, Gutkind JS, Irani K, Goldschmidt-Clermont PJ, Finkel T. Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem J 1996, 318:379-382. 1217632, 8809022.
49. Rygiel TP, Mertens AE, Strumane K, van der Kammen R, Collard JG. The Rac activator Tiam1 prevents keratinocyte apoptosis by controlling ROS-mediated ERK phosphorylation. J Cell Sci 2008, 121:1183-1192. 10.1242/jcs.017194, 18349077.
50. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996, 98:2572-2579. 10.1172/JCI119076, 507715, 8958220.
51. Zhang HJ, Zhao W, Venkataraman S, Robbins ME, Buettner GR, Kregel KC, Oberley LW. Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species. J Biol Chem 2002, 277:20919-20926. 10.1074/jbc.M109801200, 11929863.
52. Tikoo A, Czekay S, Viars C, White S, Heath JK, Arden K, Maruta H. p190-A, a human tumor suppressor gene, maps to the chromosomal region 19q13.3 that is reportedly deleted in some gliomas. Gene 2000, 257:23-31. 10.1016/S0378-1119(00)00387-5, 11054565.
53. Wang DZ, Nur EKMS, Tikoo A, Montague W, Maruta H. The GTPase and Rho GAP domains of p190, a tumor suppressor protein that binds the M(r) 120,000 Ras GAP, independently function as anti-Ras tumor suppressors. Cancer Res 1997, 57:2478-2484.
54. Wolf RM, Draghi N, Liang X, Dai C, Uhrbom L, Eklof C, Westermark B, Holland EC, Resh MD. p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3. Genes Dev 2003, 17:476-487. 10.1101/gad.1040003, 196001, 12600941.